Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates

Guardant Health (GH) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to loss of $0.67 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 15.79%. A quarter ago, it was expected that this provider of oncology testing services would post a loss of $0.72 per share when it actually produced a loss of $0.46, delivering a surprise of 36.11%. Over the last four quart ...